I’ve reported previously (see here) on the diabetes monitors from Israel’s DreaMed. The US FDA has just given approval to DreaMed’s Advisor Pro, to add to its EU approval. The software tells Type 1 diabetics how much insulin to use, without having to contact a physician.

https://www.jpost.com/Israel-News/DreaMed-wins-FDA-clearance-for-AI-insulin-recommendation-technology-601846